🟢 Voyager Therapeutics is trading 5.88% up in pre-market

Voyager Therapeutics is trading 5.88% up at $3.60 in pre-market after closing at $3.40 on September 8, 2026; no specific catalyst has been identified.

• The company presented at the Wells Fargo Healthcare Conference, discussing upcoming tau-program data, VY1706 clinical enrollment, and NeuroShuttle development.
• Available coverage does not explicitly link those comments to the September 9 pre-market move.
• No separate September 9 company announcement was identified.